Red and near-infrared light interacts with cells primarily by being absorbed by cytochrome c oxidase, the terminal enzyme of the mitochondrial electron transport chain. Published research indicates that when CCO absorbs photons in the 600 to 700 nm (red) and 760 to 850 nm (near-infrared) ranges, it undergoes conformational changes that reduce competitive inhibition by nitric oxide. This restores and accelerates electron flow through complex IV, increasing the proton gradient across the inner mitochondrial membrane and boosting ATP synthesis.
Secondary effects include transient reactive oxygen species (ROS) signaling and the activation of transcription factors that modulate gene expression. The mechanism is often described as the molecular why behind the broad tissue-level effects observed in photobiomodulation (PBM) research.
What Is Cytochrome C Oxidase and Why Does It Matter?
Cytochrome c oxidase (CCO), also designated complex IV, sits at the terminal end of the mitochondrial electron transport chain (ETC). Its job is straightforward in concept: it accepts electrons from cytochrome c and transfers them to molecular oxygen, producing water as a byproduct. This electron transfer drives proton pumping across the inner mitochondrial membrane, generating the electrochemical gradient that powers ATP synthase (complex V).
Without adequate CCO activity, the entire ETC slows. Less proton gradient means less ATP. In tissues with high energy demands, particularly neurons, cardiomyocytes, and skeletal muscle cells, even modest reductions in CCO function translate quickly into reduced cellular performance.
CCO is not a simple enzyme. It contains four metal redox centers: two copper centers (CuA and CuB) and two heme iron centers (heme a and heme a3). These centers give CCO distinct optical properties, meaning the enzyme absorbs light at specific wavelengths. That optical character is the starting point for the entire photobiomodulation mechanism.
As the foundational work of Tiina Karu at the Russian Academy of Sciences demonstrated across multiple decades, CCO functions as the primary intracellular photoacceptor for red-to-near-infrared radiation, a role confirmed by action spectrum studies that mapped biological response peaks to CCO's known absorption bands.
What Is the Absorption Spectrum of Cytochrome C Oxidase?
CCO's absorption spectrum has two primary windows in the therapeutic light range, one in the red band and one in the near-infrared band. Karu and colleagues documented absorption activity centered around 665 nm and 810 nm, with the broader active range spanning roughly 600 to 700 nm (red) and 760 to 850 nm (near-infrared). The oxidation state of the enzyme influences which wavelengths are absorbed most strongly. The relatively oxidized form of CCO absorbs preferentially in the 650 to 680 nm range, while the relatively reduced form shows stronger absorption in the 710 to 790 nm region.
This dual-window absorption spectrum maps well to the wavelengths used in commercial photobiomodulation devices. The table below compares the known CCO absorption bands to representative wavelengths used in PBM research and practice.
Wavelength Comparison Table
|
Wavelength |
Spectral Band |
Relationship to CCO Absorption |
Typical Application in PBM Research |
|
633 nm |
Red |
Within primary red absorption band (600 to 700 nm); absorbed by oxidized CCO |
Early LLLT research; dermatological and wound studies |
|
660 nm |
Red |
Near the center of the primary red absorption peak (~665 nm) |
Wound healing, local inflammation, skin research |
|
810 nm |
Near-infrared |
Near the center of the NIR absorption peak (~810 nm); stronger tissue penetration |
Neurological, musculoskeletal, and transcranial PBM studies |
|
850 nm |
Near-infrared |
Within the NIR absorption band (760 to 850 nm) |
Musculoskeletal, recovery, and combined-wavelength protocols |
How Does Light Absorption by CCO Lead to More ATP?
Understanding the proposed step-by-step mechanism helps clarify both what the evidence supports and where scientific discussion continues.
Under normal conditions, CCO operates efficiently. However, in states of cellular stress, inflammation, or hypoxia, nitric oxide (NO) accumulates and binds competitively to the heme iron and copper centers of CCO. NO competes directly with molecular oxygen at the enzyme's active site, slowing electron transfer and suppressing ATP production. This NO-mediated inhibition is reversible, and photodissociation offers one proposed pathway to reverse it.
Step-by-Step Molecular Mechanism
-
Step 1: Photon absorption: A red or NIR photon is absorbed by CuA, CuB, heme a, or heme a3 centers within CCO.
-
Step 2: Nitric oxide photodissociation: The absorbed energy displaces NO from its binding site, lifting competitive inhibition of oxygen reduction.
-
Step 3: Electron transfer resumes: Oxygen can again bind to the active site, and electron transfer to O2 accelerates.
-
Step 4: Proton gradient increases: Electron transfer drives proton pumping across the inner mitochondrial membrane, raising mitochondrial membrane potential.
-
Step 5: ATP synthase activation: The restored electrochemical gradient drives ATP synthase (complex V) to produce ATP from ADP and inorganic phosphate.
-
Step 6: Transient ROS signaling: A brief, controlled rise in reactive oxygen species (ROS) from the mitochondria activates redox-sensitive transcription factors.
-
Step 7: Gene expression changes: Transcription factors including NF-kB and AP-1 upregulate cytoprotective, anti-inflammatory, and growth-related genes.
Karu's research on mitochondrial signaling pathways confirmed that this sequence can be modulated by ligands that bind directly to CCO's catalytic center, including NO, and that light-induced changes in CCO redox status propagate into the cell as a broader signaling event. Eells and colleagues further documented this mitochondrial signaling pathway in the context of tissue models, providing early translational context for the CCO mechanism in mammalian tissue.
What Downstream Effects Follow ATP Increase?
ATP increase is not the only outcome downstream of CCO photoactivation. The brief, controlled rise in mitochondrial ROS acts as a signaling molecule rather than a damaging oxidant. Hamblin's review describes how this ROS pulse activates redox-sensitive transcription factors, most notably NF-kB, driving expression of genes involved in cell survival, anti-apoptotic pathways, and antioxidant defenses.
This retrograde mitochondrial signaling helps explain how a brief exposure to light can produce biological effects that persist for hours or days. The light initiates a molecular cascade that proceeds through cellular signaling on its own biological timescale.
Additional downstream effects reported in the PBM literature include increases in cyclic AMP (cAMP), calcium ion modulation, upregulation of heat shock proteins, and, in the work of Arany and colleagues, photoactivation of latent TGF-beta1, a signaling protein with roles in tissue repair, inflammation regulation, and stem cell activity. These pathways illustrate that CCO photoactivation is a trigger point, not the entire story.
Who Established the Foundational Evidence for This Mechanism?
The CCO-as-photoacceptor hypothesis has been built over decades through converging lines of research.
-
Tiina Karu (Institute of Laser and Information Technologies, Russian Academy of Sciences): Produced action spectrum studies and mechanistic analyses across several decades establishing that PBM response peaks in cell cultures matched CCO's absorption spectrum and that CCO's copper and heme centers serve as the likely photoacceptors.
-
Michael Hamblin (Harvard Medical School, later University of Arizona): Authored comprehensive mechanism reviews synthesizing the global PBM literature. His review with de Freitas and his paper in AIMS Biophysics both position CCO at the center of the proposed mechanism while noting alternative and complementary pathways.
-
Janis Eells (University of Wisconsin-Milwaukee): Provided translational evidence connecting mitochondrial CCO signaling to tissue-level outcomes in wound models, documenting the signaling cascade from NIR photon absorption to accelerated tissue repair.
-
Praveen Arany (University at Buffalo): Extended the downstream picture by identifying TGF-beta1 photoactivation as a discrete molecular mechanism operating alongside the CCO-NO model, adding mechanistic depth beyond ATP alone.
What Remains Debated or Unresolved?
The NO-photodissociation model is the prevailing explanation for how CCO photoactivation leads to increased ATP, but it is not the only proposal in the literature, and not every aspect of PBM can be fully accounted for by CCO alone.
Several alternative or complementary mechanisms have been proposed:
-
Light-sensitive ion channels: Hamblin and others have identified calcium ion channels, possibly mediated by opsin-type photoreceptors, as a secondary chromophore system that may account for some PBM effects at wavelengths where CCO absorption is weaker.
-
Water structuring: Some researchers have proposed that structured or nanostructured water near light-sensitive ion channels could play a role at longer near-infrared wavelengths. This hypothesis remains speculative.
-
Direct gene regulation: Karu proposed that some PBM effects may involve gene expression changes independent of the ATP-ROS cascade, a possibility that Arany's TGF-beta1 work has further explored.
The scientific community has not converged on a single unified mechanism. What the evidence does strongly support is that CCO is the primary photoacceptor for red and near-infrared light, that photon absorption produces measurable changes in CCO activity and ATP production, and that these events initiate broader signaling cascades whose full details remain under active investigation.
Connecting Mechanism to Device Specifications
Understanding the cellular mechanism informs how to evaluate device specifications. Wavelength choices of 660 nm and 850 nm align directly with the two primary CCO absorption windows. The red window targets superficial tissue, while the near-infrared window provides greater penetration depth for deeper musculoskeletal structures.
Irradiance determines the photon delivery rate, and fluence is irradiance multiplied by time. Typical sessions in the published literature run approximately 10 to 20 minutes at a given working distance. The biphasic dose response documented throughout the PBM literature means more time or higher power does not always produce a better outcome.
Wavelength is not a cosmetic branding choice, and irradiance is not merely a marketing number. They are the photobiological variables that determine whether a device delivers photons in the range and density where CCO absorbs them.
Our whole-body systems are meticulously engineered around this strict mitochondrial science. The OvationULT ($59,997) features an innovative zero-gravity design contoured specifically to address the major engineering flaw of standard flat beds by keeping the client perfectly close to the light arrays for maximum photon delivery. For high-capacity operations or facilities serving larger users up to 6'8, the PremierRLT ($69,997) expands that footprint with additional panels near the facial area. Both commercial beds are carefully assembled right here in our Las Vegas, NV warehouse and operate seamlessly on a standard 120V outlet, making them high-profit, completely hands-off revenue generators. If your practice focuses primarily on targeted local applications, our compact Foot Revitalizer panel array delivers the exact same precise wavelength science for foot neuropathy at a low-friction price point of $1,495.
Frequently Asked Questions
Is cytochrome c oxidase the only cellular target of red and near-infrared light?
CCO is the most extensively studied and best-supported primary photoacceptor, but the published literature also identifies calcium ion channels and other potential chromophores as secondary targets. The evidence is strongest for CCO as the primary molecular entry point for therapeutic red and NIR wavelengths.
Why do both red (660 nm) and near-infrared (850 nm) wavelengths appear in PBM devices?
Because CCO has two distinct absorption windows, one in the red band and one in the near-infrared band, devices using both wavelengths are designed to engage CCO across both spectral ranges. Additionally, red light penetrates less deeply and is more relevant to superficial tissues, while near-infrared reaches deeper musculoskeletal structures.
Is the CCO mechanism specific to laser light, or do LEDs work the same way?
The photochemistry of CCO is driven by photon wavelength and energy density, not by coherence. Published research indicates that LED-based devices at appropriate wavelengths and irradiance levels produce comparable cellular responses to laser sources at the same wavelength. The photoacceptor responds to the photon regardless of the source type.